P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL

ABSTRACT:

SUBMITTER: Montefusco V 

PROVIDER: S-EPMC10431092 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature